Brind.

NeoGenomics operates laboratories across the United States and the United Kingdom.

8 reports, 3 independent Updated Sep 11
Gone quiet
Reports
8
Developments
1
Repetition
88%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

NeoGenomics operates laboratories across the United States and the United Kingdom.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • tickerreport.com
  • stockhouse.com
  • StockStoryTesting & Diagnostics Services Stocks Q2 Teardown: NeoGenomics (NASDAQ:NEO) Vs The Rest The end of the earnings season is always a good time to take a step back and see who shined (and who not so muc
  • StockStoryNeoGenomics (NASDAQ:NEO) Misses Q2 Sales Targets, Stock Drops 15.8% Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) missed Wall Street’s revenue expectations in Q2 CY2025, but sales ro
  • StockStory3 of Wall Street’s Favorite Stocks We’re Skeptical Of The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should
  • StockStoryQ1 Earnings Highlights: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Testing & Diagnostics Services Stocks As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in t
  • Unknown outlet
1 more outlet ran the same wire story